Category Archives: Noradrenalin Transporter

Supplementary Materialsijms-20-06172-s001

Supplementary Materialsijms-20-06172-s001. CBD, respectively. IL-18 was the only marker that correlated with the MADRS-S ratings of the sufferers. Neuronal growth elements (NGFs) were considerably improved in plasma through the sufferers, as was the common plasma GABA focus. GABA modulated the discharge of seven cytokines in anti-CD3-activated peripheral bloodstream mononuclear cells (PBMCs) through the sufferers. The analysis reveals significant adjustments in the plasma structure of little substances during despair and recognizes potential peripheral biomarkers of the condition. (%): Current depressive event25 (100)Main depressive disorder20 (80)First depressive event3 (12%)Continuing unipolar despair 17 (68%)Bipolar disorder5 (20%)Type I4 (16%)Type II or uncategorized1 (4%)Any panic 7 (28%)Various other psychiatric diagnoses *4 (16%)Prior hospitalization for despair ((%))22 (88%)MADRS-S rating (suggest (SD))33.8 (7,4)Medication, (%): Other anxiolytic medicines **11 (44%)Antidepressive treatment ***21 (84%)Antipsychotics6 (24%)Benzodiazepines5 (20%)Z-analogues6 (24%) Open up in another window * One case of Aspergers and dyslexia, one case of ADHD, one case shown psychotic symptoms, and something individual provides since this scholarly research committed suicide. ** Sedating antihistamines, phenothiazines. *** SSRI, SNRI, disposition stabilizers and atypical antidepressants. 2.2. Inflammatory Markers in Plasma from CBD and Sufferers Immune system cells to push out a large numbers of little proteins, called inflammatory markers collectively, which may possess a protective act or work as pro-inflammatory molecules. We investigated if the varieties of inflammatory markers in plasma differed between CBD as well as the sufferers. We assessed the plasma degrees of 92 inflammatory markers which are most commonly connected with irritation using an Olink irritation panel analyzed using a multiplex closeness expansion assay (PEA) (Desk S3) ( The technology uses matched antibodies for the various inflammatory markers, such as cytokines, growth factors, mitogens, chemotactic, soluble receptors, and other pro-inflammatory molecules, and this allows a comparison of the levels of the same marker in samples from, e.g., CBD and the patients. However, the assay format does not SERPINB2 support a comparison of the absolute levels of one marker to another as the affinities of the antibodies for their cognate targets may vary. MCH-1 antagonist 1 In plasma from both CBD and the patient group, 67 inflammatory markers out of 92 analyzed proteins were detectable with values above the limit of detection (LOD) (Physique 1A; Table S4). Importantly, 13 inflammatory markers were significantly higher in plasma from the patients compared to markers in plasma from CBD (Body 1B). Open up in another window Body 1 Inflammatory markers in plasma from control bloodstream donors (CBD) and sufferers. (A) Verification of 92 inflammatory markers (Desk S3) in plasma examples from CBD (= 26) and sufferers (= 25) by Proseek Multiplex PEA irritation panel I discovered the appearance of 67 markers (Desk S4). Data are provided by 2NPX (Normalized Proteins Expression) beliefs as floating pubs (least to optimum) organized in descending purchase from the mean appearance degree of inflammatory markers. (B) MCH-1 antagonist 1 Inflammatory markers using a considerably changed appearance level within the plasma of sufferers in comparison to CBD. The distinctions between groups had been assessed by non-parametric KruskalCWallis ANOVA on rates with Dunns post hoc check. Data are shown being a whiskers and container overlapped using a scatter dot story. * p < 0.05, ** p < 0.01. 2.3. Ramifications of Age group on Degrees of Inflammatory Markers in Plasma Because the sufferers varied in age group, we analyzed if there have been any correlations between age group and the amount of inflammatory markers in plasma from both groupings. Ten inflammatory markers correlated with age group in CBD (Body 2A; Desk S5) and 21 within the sufferers (Body 2B; Desk S5). Six inflammatory markers, including IL-8, CXCL9, MCH-1 antagonist 1 HGF, VEGF-A, OPG, and MMP-1, correlated with age group both in teams and could reveal regular maturing functions instead of disease thus. Another three inflammatory markers, comprising TGF-, EN-RAGE, and OSM, just correlated with age group in the sufferers and, interestingly, had been also increased within the plasma from sufferers in comparison to CBD (Body 1B and Body 2B). The most powerful correlation.

Supplementary Materialscb0c00030_si_001

Supplementary Materialscb0c00030_si_001. macrophages, can survive and replicate in web host phagosomes, while withstanding the hostile acidic environment. The mycobacterial cell envelope is normally one aspect that plays a part in the resilience of within web host cells.2 It really is a multilayered hurdle, made up of many organic lipids, glycolipids, and glycoproteins, a lot of which are exclusive to mutants not capable of synthesizing mycolipenic acidity, and deficient in DAT and PAT therefore, display aggregation in liquid lifestyle, because of flaws in capsule attachment, indicating that certain of the features of DAT and PAT is anchoring the hydrophilic capsule towards the hydrophobic mycolic acidity layer from the mycobacterial cell envelope.24,29?31 However, in aerosol infection mouse choices using DAT/PAT-deficient mutants, there have been no noticed differences in development, in comparison to wild-type substances, recommending that DAT/PAT itself isn’t essential for survival.29 Recently, cell wall componentssuch as trehalose dimycolate (TDM, also known as cord factor)have been identified as high-affinity ligands for macrophage-inducible C-type lectin (Mincle).32?34 The activation of Mincle results in downstream expression of cytokines, chemokines, and growth factors and leads to recruitment of inflammatory cells to the site of activation like a central part of the innate immune response to cell wall glycolipids have been identified as Mincle activators,34,35 and there is growing desire for using these Mincle ligands for the development of novel vaccine adjuvants.36 In 2017, it was demonstrated that a DAT-containing extract from also activated Mincle.35 We realized that, apart from minute amounts of contaminants in natural isolates that can influence the effects, the activation of Mincle could very well be dependent on the precise structure of the DAT. Consequently, we wanted to synthesize three different DATs with exactly defined molecular structure and stereochemistry to study their Mincle activating properties and to assess the influence of the acyl substituents on Mincle binding. Furthermore, we targeted to confirm the presence of these three DATs in different strains of Strains Having completed the total synthesis of DAT1, DAT2, and DAT3 with constructions as described in the literature,17 we wanted to determine if the synthesized glycolipids match the constructions of natural products present in virulent strains of of each compound within the expected experimental error of 3C4 ppm. Collision-induced fragmentation (see the data given in the Assisting Information) of the natural and synthetic DATs yielded interpretable cleavages (Number ?Number22C, H-transfers not shown) that supported the general structures and connectivity. Co-injection (Number ?Number22B) of synthetic standards and organic lipid mixtures showed a chromatographic match for DAT1 and DAT3. However, synthetic DAT2 eluted more than a minute earlier than the natural compound. Thus, whereas the identity of DAT1 and DAT3 can be considered to have been founded beyond a reasonable doubt, we conclude that material with the structure of Rabbit Polyclonal to SLC27A4 synthetic DAT2 does not happen in the H37Rv strain. This may mean that an isomer of the proposed structure of DAT2 is present with this strain, or the structure of natural DAT2 has been incorrectly assigned.15 Open in a separate window Number 2 Detection of DAT variants in strains. Lipid components from four different strains were analyzed via high-performance liquid chromatographyCmass spectroscopy (HPLC-MS): laboratory AG 957 strain H37Rv, and three medical isolates named j257, j011, and j117. Extracted ion chromatograms of ions related with the ammonium adduct of DAT1 (determined = 948.733), DAT2 (= 1006.775), and DAT3 (= 988.764) showed beliefs in keeping with those expected from AG 957 DATs. (B) Evaluation with man made standards demonstrated chromatographic coelution for DAT1 and DAT3 however, not for DAT2, indicating that man made DAT2 isn’t identical to organic DAT2. (C) CID evaluation of the AG 957 criteria and organic substances (find data provided in the Helping Details) yielded fragmentation patterns diagnostic for the known buildings. Mincle Activation by DAT1, DAT2, and DAT3 We.

Supplementary MaterialsSupplementary data 1 mmc1

Supplementary MaterialsSupplementary data 1 mmc1. women and provide clinical information of their neonates. For this retrospective study, five pregnant women were admitted from Jan 21, 2020 to Feb 9, 2020 by Wuhan Union Hospital. All Pentiapine pregnant patients were 34?week pregnancy with fever or respiratory symptoms and all of them were laboratory-confirmed SARS-CoV-2 positive by real-time reverse-transcription PCR (RT-PCR). Laboratory confirmation of SARS-CoV-2 contamination was carried out using real time RT-PCR to amplify gene and gene (two genes recommended by Chinese Center for Disease Control and Prevention) [2] following the manufacturer’s instructions (BioGerm, Shanghai, China). The exams were performed on the Roche Cobas z480 Computerized PCR Analyzer. The sequences for gene amplification and recognition were: forwards primer 5-CCCTGTGGGTTTTACACTTAA-3, invert primer 5-ACGATTGTGCATCAGCTGA-3, fluorescence probe 5-FAM-CCGTCTGCGGTATGTGGAAAGGTTATGC-BHQ1-3; The sequences for gene amplification and recognition were: forwards primer 5-GGGGAACTTCTCCTGCTAGAAT-3, invert primer 5-CAGACATTTTGCTCTCAAGCTG-3, fluorescence probe 5-FAM-TTGCTGCTGCTTGACAGATT-TAMRA-3. A routine threshold value significantly less than 35 (or above 35 but significantly less than 38 for double) was thought as positive. The scientific features, lab and radiological results, healing final results and options for all of the five sufferers and their neonates had been attained, recorded and analyzed carefully. All data had been examined by three research workers. This scholarly study was approved by Wuhan Union Hospital Ethics Committee and informed consent was obtained. Between Jan 21, 2020 and Feb 9, 2020, five women that are pregnant were accepted with laboratory-confirmed SARS-CoV-2-infections (Desks 1 and S1 online). non-e of them acquired Huanan seafood marketplace exposure (Desk 1) and all of the sufferers were citizens of Wuhan. Regarding to sufferers records, only Individual 4s relative was verified with SARS-CoV-2 before starting point of her symptoms, and others did not have got close connection with COVID-19 sufferers within 14?times before symptoms starting point. These sufferers were aged between 23 and 34?years (common 29?years) (Table 1), all of their fetuses were healthy and had normal development during pregnancy. Patient 1 was initially admitted due to obstetric reasons, while Individuals 2C5 were admitted due to pneumonia-like symptoms such as fever and dry cough (Table 1). During medical course of COVID-19 illness, the additional symptoms included fatigue and dyspnea (Table 1). Fever was the most common symptom, and could be intermittent, enduring for any median duration of 8?days (range 2C11?days) (Table 1). Dry cough was significant, often aggravated by supine position. Table 1 Clinical features of the pregnant women with COVID-19 pneumonia. thead th rowspan=”1″ colspan=”1″ /th th colspan=”2″ Pentiapine rowspan=”1″ Patient 1 /th th colspan=”2″ rowspan=”1″ Individual 2 /th th colspan=”2″ rowspan=”1″ Individual 3 /th th colspan=”2″ rowspan=”1″ Individual 4 /th th colspan=”2″ rowspan=”1″ Individual 5 /th /thead Age group (calendar year)3425233428SexFemaleFemaleFemaleFemaleFemaleGestational age group at entrance (weeks?+?times)38 weeks?+?6 times34 weeks?+?4 times37 weeks?+?3 times36 weeks?+?4 times37 weeksPregnancy/birth1/01/02/05/11/0Huanan sea food marketplace exposureNoNoNoNoNoReasons for hospitalizationWait for parturition, stomach painPregnancy with viral pneumoniaPregnancy with viral pneumoniaPregnancy with viral pneumoniaFever, colporrhagiaChronic illnessNoNoNoNoNoInitial symptomsFeverFeverFeverFeverFever, coughSeverity of pneumoniaMildMildMildMildMild24?h just before to 72?h after onset of parturitionAntepartum 24?hPostpartum 72?hAntepartum 24?hPostpartum 72?hAntepartum 24?hPostpartum 72?hAntepartum 24?hPostpartum 72?hAntepartum 24?hPostpartum 72?hFeverNoYesNoNoNoYesNoNOYESYESHighest heat range(C)36.537.6NA36.838.738.536.436.838.139.3Chest distressNoYesNoNoYesNoNoNONONOMyalgiaNoNoNoNoNoNoNoNONONONasal congestionNoNoNoNoNoNoNoNONONOCoughNoNoNoNoYesYesNoNOYESYESSore throatNoNoNoNoNoNoNoNONONOSputum ProductionNoNoNoNoNoNoNoNOYESYESDyspneaNoNoNoNoYesNoNoNONOYESHemoptysisNoNoNoNoNoNoNoNONONOOtherAbdominal, anorexiaNoNoNoNoNoNoNOAbdominalNOLowest SpO2 (%)93%C96%93% with air inhalation99%99%NDND94%94%ND94% with air inhalationOxygen supportNoNasal cannula (3?L/min)Sinus cannula (2?L/min)Sinus cannula (2?L/min)NoNasal cannula (3 ?L/minC5?L/min)NoNasal cannula (3?L/min)NONasal cannula (10?L/min)Duration of fever (time)7211811Days from illness onset to dyspnoeaNoneNone4NoneNoneDiagnosis methodReal-time PCRReal-time PCRReal-time PCRReal-time PCRReal-time PCRDays from admission to SARS-CoV-2 recognition5051?day just before entrance3Surgical indications39 weeks pregnant, stomach painViral LAMC2 pneumoniaViral pneumoniaViral pneumoniaEutociaDelivery modeCesarean sectionCesarean sectionCesarean sectionCesarean sectionEutociaTime between indicator starting point and neonate delivery (time)6115108Antiviral therapyYesYesYesYesYesAntibiotic therapyYesYesYesYesYesCorticosteroidNoYesNoYesYes Open up in another screen ND: not detected; NA: unavailable. Based on the description of illness intensity by WHO interim guide for COVID-19 [3], all of the sufferers developed light pneumonia Pentiapine and provided birth to infants during hospitalization (Desk 1). The proper period in the onset of symptoms to delivery for these sufferers was 6, 10, 5, 10 and 8?times, respectively. Their indications for baby delivery had been: Individual 1 (39 weeks) received C-section because of abdominal pain; Individual 2 (34 weeks?+?4 times), Individual 3 (37 weeks?+?3 days) and 4 (36 weeks?+?4 days) were physiologically ready for.

Data Availability StatementThe datasets generated because of this study are available on request to the corresponding author

Data Availability StatementThe datasets generated because of this study are available on request to the corresponding author. blood platelets, four diacyl and two acyl-alkyl PCs (but not lysoPCs) were significantly altered. Our data show that lipids are changed in CAA with a specific pattern, and we provide for the first time evidence that selected platelet and plasma PCs may help to characterize CAA. = 8) were generated as described in detail by us (1). All animal experiments were approved by the Austrian Ministry of Science and Research (BMWF-66.011/011_WF/V/3b/2015) and conformed to the Austrian guidelines on animal welfare and experimentation. Briefly, 5-month-old wild-type mice (C57BL/6N) were either not really treated (handles) or treated with vascular risk elements for 35 or 56 weeks (Body 1). Vascular risk elements included 2% cholesterol meals, copper in the normal water (1 mg/L), streptozotocin (to stimulate diabetes; maximum dosage 50 mg/kg), lipopolysaccharides (to stimulate irritation; 1.25 mg/kg), and public tension (induced by changing the cage companions). Mice had been anesthetized with 100 mg/kg ketamine and 10 mg/kg xylazine. Bloodstream was used directly from the heart and collected in EDTA tubes. Subsequently, the blood was centrifuged (10 min, 100 for 10 min, and the pellets were resuspended in 100 L of FACSFlow (BD FACSFlow, Erembodegem, Aalst, Belgium). FACS analysis was instantly performed having a BD FACScan. Targeted Metabolomic Analysis of Plasma and Platelets The endogenous metabolites were analyzed having a targeted quantitatively and qualitatively controlled metabolomics assay by using the AbsoluteIDQ p150 Kit (Biocrates Life Technology AG, Innsbruck, Austria). This validated assay allows the quantification and comprehensive recognition of 163 endogenous metabolites including among others 77 Personal computers (Personal computer aa = diacyl x:y; Personal computer ae = acylalkyl x:y) and 40 acylcarnitines (Cx:y). The AbsoluteIDQ p150 Kit was performed according LDN-27219 to the manufacturer’s instructions as reported by us (16, 17). In short, 10 L of sample combination was pipetted onto filter places suspended in the wells of a 96-well filter plate. The filter plate LDN-27219 was fixed on top of a deep-well plate serving like a receiving plate for the extract later on, that is, a combi-plate structure. After drying under a nitrogen stream for 30 min, 50 L of a 5% phenylisothiocyanate answer was added to enable derivatization LDN-27219 of amino acids. After 20 min of shaking and nitrogen drying, 300 L of 5 mM ammonium acetate in methanol was added to the wells. After 30 min of incubation, the combi-plate was centrifuged to move the ingredients in to the lower getting deep-well plate, that was detached in the upper filter plate then. After adding another 300 L of 5 mM ammonium acetate in methanol towards the briefly and ingredients shaking, the dish was put into the autosampler from the stream injection evaluation (FIA)Ctandem mass spectrometry (MS/MS) program for evaluation. The FIA-MS/MS program contains a Knauer K-1001 LC pump (Knauer, Berlin, Germany), a CTC-PAL HTS9 autosampler (CTC Analytics AG, Zwingen, Switzerland), and a QTrap 3200 mass spectrometer (Sciex, Toronto, Ontario, Canada). The shot quantity was 30 L. The stream rate was established to 30 L/min. Metabolite concentrations (M) had been automatically calculated with the MetIDQ program area of the AbsoluteIDQ p150Kit. Traditional western Blot Analysis Traditional western blot evaluation was performed as previously defined by us (21). Platelet examples (?80C) were thawed and pipes dissolved in 100 L ice-cold PBS containing a protease inhibitor cocktail (P-8340; Sigma). Examples had been sonicated using an ultrasonic gadget after that, centrifuged at 14,000 for 10 min at 4C; the ingredients had been denatured (10 min, 70C), and 18 g was packed onto 10% SDS-polyacrylamide gels (Thermo Fisher Scientific, Vienna, Austria), separated for 35 min at 200 V and lastly electrotransferred to nylon-PVDF CR2 Immobilon-PSQ membranes for 20 min at 30 V in 20% methanol blotting buffer. Next, blots had been obstructed for 30 min in preventing buffer; incubated with principal antibody against APP (Abcam stomach32136, 1:2,000, Cambridge, UK), or Compact disc41 (Abcam stomach63323, 1:2,000), or actin (1:1,000, A2066; Sigma, Vienna, Austria) at 4C right away; washed; and incubated in alkaline phosphataseCconjugated antiCrabbit IgG for 30 min then. After washing, destined antibodies had been detected using a sophisticated chemiluminescence program and visualized with a cooled CCD surveillance camera (SearchLight; Thermo Fisher Scientific). Statistical Evaluation Statistical evaluation was performed with evaluation of variance (ANOVA) and a following Fisher least factor (LSD) ensure that you comparing handles vs. remedies. Statistical results had been regarded significant at 0.05. Outcomes Lipids in Plasma of CAA Mice Around 100 lipids had been driven in the plasma of well-characterized CAA mice and in comparison to control mice (Desk LDN-27219 1). Degrees of eight aaPCs.

Serious influenza is connected with high mortality and morbidity

Serious influenza is connected with high mortality and morbidity. an specific area under curve of 0.728. We constructed an event-associated algorithm that included ARDS and lactate. Fifteen (75%) of 20 sufferers with lactate amounts 3.7 mmol/L and ARDS died, weighed against only one 1 (7.7%) of 13 sufferers with regular lactate amounts and without ARDS. We discovered laboratory and clinical predictors of mortality that could assist in the care of critically sick influenza individuals. Identification of the prognostic markers could possibly be improved to prioritize essential examinations that could be useful in identifying patient outcomes. check for numerical factors. The LDE225 reversible enzyme inhibition differences had been regarded significant at 0.05. Significant factors in the univariate analyses had been entered right into a multivariate logistic regression model to recognize indie predictors of mortality in critically sick influenza sufferers. We used recipient operating quality curves (ROC) to choose cutoff factors for indie numerical predictors regarding LDE225 reversible enzyme inhibition to visual evaluation of the best awareness and specificity. We after that made an event-based algorithm as a straightforward predictive device using 2 factors with statistically significant organizations with mortality (worth significantly less than or add up to 0.001) in the multivariate model. Data were analyzed and entered using the Statistical Bundle for the Public Sciences statistical software program (edition 19.0; SPSS Inc., Chicago, IL, USA). 3. Results 3.1. Patient Characteristics In total, 102 critically ill individuals (97% in medical ICUs and 3% in medical ICUs) comprising 62 males and 40 ladies, having a median age of 62 years with laboratory-confirmed influenza computer virus infection were assessed. The median time from illness onset to hospital demonstration was three days (range, 1C14). Among the 102 individuals, three did not receive antiviral therapy (either oseltamivir or peramivir). Of the 99 individuals who received antiviral therapy, 89 individuals received oseltamivir and five received peramivir; five individuals received both oseltamivir and peramivir during their hospitalization. Of the 94 individuals who received oseltamivir therapy, 68 (72.3%) began taking oseltamivir 48 h after the onset of illness. Among the 10 individuals who received peramivir, 60% received antiviral therapy 48 h after the onset of symptoms. Among 102 individuals, influenza A computer virus was recognized in 77 (75.5%) individuals (33.3% for pdm09 A/H1, 7.8% for H3N2 and 28.4% for untypable influenza A), influenza B computer virus in 24 (23.5%), and concurrent influenza A (untypable) and influenza B in 1 (0.9%). The LDE225 reversible enzyme inhibition medical characteristics of the included individuals are summarized in Table 1 and Table 2. Table 1 Characteristics and diagnostic methods of individuals with severe influenza. = 102)= 61)= 41)Value(%) 0.06820C49 year 20 (19.6)11 (18)9 (22) 50C6438 (37.3)19 (31.1)19 (46.3) 65 12 months44 (43.1)31 (50.8)13 (31.7) Woman gender, (%)40 (39)23 (37.7)17 (41.5)0.836Body mass index, median (range)23.25 (16.7C37.8) (= 86)23.8 (16.7C35.7) (= 55)22.7 (17.8C37.8) (= 31)0.583 Underlying condition, (%) Bronchial asthma7 (6.9)4 (6.6)3 (7.3) 0.99Hypertension56 (54.9)38 (62.3)18 (43.9)0.073Type 2 diabetes mellitus45 (44.1)28 (45.9)17 (41.5)0.689Chronic kidney disease16 (15.7)13 (21.3)3 (7.3)0.094End stage renal disease9 (8.8)5 (8.2)4 (9.8) 0.99Chronic obstructive pulmonary disease8 (7.8)7 (11.5)1 (2.4)0.139Liver cirrhosis 6 (5.9)3 (4.9)3 (7.3)0.682qSOFA, median (range)1 (0C3) (= 99)1 (0C3) (= 60)1 (0C2) (= 39)0.906SOFA, median (range)6 (2C16) (= 59)6 (2C16) (= 34)7 (3C14) (= 25)0.263Times from illness onset to hospital demonstration, days, median (range)3 (1C14)2 (1C10)3 (1C14)0.414Times from illness onset to fatality, day time, median (range)–18.5 (2C53)-Hospital length of stay, days, median (range)23 (1C107) 32 (2C107) 14 (1C53) 0.001Stay in intensive care and attention unit, (%)98 (96.1)60 (98.3)38 (92.7)0.177Use antibiotic at demonstration, (%)100 (98) 60 (98.4) 40 (97.6) 0.99Use oseltamivir, (%)94 (92.2)56 Rabbit polyclonal to beta Catenin (91.8)38 (92.7) 0.99Use oseltamivir 48 h after onset of illness, N/total (%)68/94 (72.3) 39/56 (69.6)29/38 (76.3)0.639Use peramivir, (%)10 (9.8)8 (13.1)2 (4.9)0.793Use peramivir 48 h after onset of illness, (%)6/10 (60)5/8 (62.5)1/2 (50) 0.99Use statin, (%)21 (20.6)14 (23)7 (17.1)0.610Use metformin, (%)17 (16.7)13 (21.3)4 (9.8)0.177Use vasopressor44 (43.1)15 (24.6) 29 (70.7) 0.001 Diagnostic methods for influenza, (%) Positive of influenza rapid test51/93 (54.8)34/56 (60.7)17/37 (45.9)-Positive of RT-PCR for influenza94/98 (95.9)59/61 (96.7)35/37 (94.6)-Positive of throat influenza viral culture 37/95 (38.9)23/59 (39)14/36 (38.9)- Influenza computer virus subtype, (%) Influenza A77 (75.5)44 (72.1)33 (80.5)0.360pdm 09 H1N134 (33.3)23 (37.7) 11 (26.8)0.290H3N28 (7.8)7.